在纳米粒子治疗癌症中的p53的作用
Olga Szewczyk-Roszczenko1, Nikolai A Barlev2,3,4
1Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, Poland.
Cells
|December 22, 2023
概括
通过纳米医药恢复癌细胞中的瘤抑制剂p53基因功能显示出有希望. 然而,目前基于p53的疗法面临着有效性挑战,需要新的方法来实现更广泛的临床应用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 纳米医学是一种纳米医学.
背景情况:
- p53基因是一个关键的人类瘤抑制剂,对细胞循环停止和亡至关重要.
- 在大多数癌症中,p53突变或沉默是普遍存在的,这凸显了它在癌症发展中的重要性.
- 激活的野生型p53可以诱导邻近癌细胞的亡 (旁观者效应).
研究的目的:
- 通过纳米医学审查p53向癌症治疗的当前进展.
- 讨论提高基于p53的纳米药物的疗效的新策略.
- 解决目前在p53-无活化癌症中的p53向方法的局限性.
主要方法:
- 通过纳米粒子传递p53编码DNA或RNA的系统传递.
- 在体外和体外对p53纳米医学的可行性研究.
- 对基于p53的癌症治疗方法的现有文献的综述.
主要成果:
- 通过纳米粒子介导的p53 DNA/RNA的输送对于癌症治疗是可行的.
- 一种基于p53的疗法 (gendicine) 在中国已获得批准.
- 目前基于p53的疗法在p53失活的癌症中表现出不充分的疗效.
结论:
- 由于p53在亡中的作用,p53向疗法是癌症治疗的有希望的策略.
- 克服有效性限制对于p53纳米医学的广泛临床应用至关重要.
- 需要对新方法进行进一步的研究,以改进基于p53的癌症疗法.
更多相关视频
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
28.3K
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.1K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
